Menu

Exit Strategy

Scientists come up with a better way to watch cells leave blood vessels.

Jan 1, 2014
Ruth Williams

WAYS OUT: Within a day of culturing in the microvascular device, cells can be found spread but contained within the lumen (1), extravasated and adhered to the outside of the lumen (2), penetrating the endothelial barrier and contacting the hydrogel matrix (3), extravasated and migrated away from the lumen (4), adhered within the lumen and circular in morphology (5), and occluded in small vessels (6). Inset: Zoomed-out view of the microvessels (red) and tumor cells (green).© GEORGE RETSECK; INSET COURTESY OF MICHELLE CHEN, INTEGR BIOL, 5:1262-71, 2013

When a cancer becomes metastatic, its cells travel from the original tumor site via the blood. Although the process of intravasation—cancer cells entering the bloodstream—has been well studied, how they exit, or extravasate, from blood vessels is less clear. Part of the problem is that previous extravasation assays have either been physiologically relevant, as in the case of using live zebrafish, or high throughput, as with microfluidic devices, but not both. Roger Kamm’s team at the Massachusetts Institute of Technology has now come up with a microfluidic device that incorporates natural vascular structures.

Previous microfluidic devices have used monolayers of endothelium—the cells that line blood vessels—to mimic the vascular environment, says Michelle Chen, lead developer of the new system. But these cells become more permeable to tumor cells when grown in a layer. Chen therefore grew her cells in 3-D microvascular networks that closely mimic natural blood vessel structure. “The permeability we’ve been able to achieve is of the same order of magnitude as what we would find in vivo,” she says.

While in vivo analysis might be desirable, it does not allow for the kind of rapid experimentation achievable with the new device. “This technique is easy to use and gives one the control to change cell type, cell density, matrix properties, et cetera,” said Muhammad Zaman, a biomedical engineer at Boston University.

Chen has already used the device to compare the extravasation abilities of two types of cancer cells and has shown that the inflammatory cytokine TNF-a increased the rate of tumor cell extravasation. (Integr Biol, 5:1262-71, 2013)

EXTRAVASATION HOW IT WORKS HIGH-RESOLUTION IMAGING HIGH THROUGHPUT PHYSIOLOGICAL APPROXIMATION
Intravital microscopy in zebrafish The fish are anesthetized, injected with fluorescent cancer cells, and observed under a microscope. Yes No Live model organism
Microfluidic 3-D microvascular networks Microscopy captures fluorescently labeled tumor cells passing through 3-D, branching endothelial cell microvessels grown in a hydrogel. Yes Yes 3-D networks mimic blood vessels, and microfluidic control mimics blood flow.

 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.